Oncology CRO Services

Accelovance is a leading oncology CRO committed to ensuring a smooth journey in the development of your compound. The Accelovance team works tirelessly as an extension of your team to optimize the timeline, conduct, budget, and quality of your oncology clinical study to maximize success.

You require a partner that will reliably deliver and assist you in navigating the complexity of oncology clinical trial development and execution. From Phase 1-IV, we have optimized our oncology service offering by dedicating staff, technology, and assets to provide you with reliable and transparent access to data to facilitate decision making. Our robust team member experience ensures exceptional execution in all development operations while offering flexible solutions to meet your specific needs. Accelovance is the dedicated partner you can count on before, during, and after your cancer clinical trial, as we share a common goal of helping your compound succeed.


Early Phase Oncology

Accelovance also differentiates itself from other cancer CROs by excelling in early phase oncology research (Phase I-II). Our unique early phase oncology offering, HERO, leverages our staff, technology, site relationships and processes to improve the efficiency in conduct and reduce the cost of your critically important trials. HERO (Helping Early Research in Oncology), offers many key features and benefits over the conventional cancer research model, including

  • Dedicated Early Phase Oncology Teams
  • Strategic Relationships with Phase I Oncology Practices
  • Rapid Study Start-up Process
  • Optimized Clinical Technology Suite
  • Just-in-Time Site Start-up for Rare Cancers

Learn more about the benefits HERO can provide to your phase I or II cancer trial:

 

Accelerate Your Early Phase Cancer Research Today

 


Cancer Clinical Research Expertise

Accelovance offers experienced oncology project teams across the globe ready to support your next oncology study.  Expertise with your specific oncology indication is critically important when selecting the right partner for clinical trial conduct. Having completed over 150 oncology clinical trials, our team is well positioned to leverage their experience to advance your development. Oncology is complex; each indication has its own nuances and challenges to surmount, and selecting the right cancer CRO for your next study requires a partner that can provide focus and dedication to you and your team. We have worked on cancer studies with a diverse range of patient populations and have built a strong network of investigator sites to support these trials. Below is a representation of Accelovance's current oncology clinical research experience by indication: 

  • solid tumors
  • breast cancer
  • lung cancer
  • skin cancer
  • brain cancer
  • gynecological cancer
  • hematological malignancies
  • cancers of the gastrointestinal (GI) system
  • cancers of the genitourinary (GU) system
  • cancers of the head and neck
  • quality of life and supportive care
  • other rare indications

Oncology Clinical Research Experience

At Accelovance, we are accelerating oncology drug development. No matter how big or small your program, we are your trusted oncology CRO. Learn how we can assist you in advancing your oncology pipeline. Have a question about our experience? Need pricing for an upcoming project?

Get In Touch With Our Oncology Team

 

Oncology CRO Services